搜索临床试验以:225Ac-J591
总计61个结果
-
Weill Medical College of Cornell UniversityPOINT Biopharma暂停
-
Weill Medical College of Cornell UniversityNational Cancer Institute (NCI); United States Department of Defense; National Institutes of Health... 和其他合作者完全的
-
Weill Medical College of Cornell University完全的
-
Modulation Therapeutics, Inc.H. Lee Moffitt Cancer Center and Research Institute招聘中
-
Erasmus Medical CenterDutch Cancer Society招聘中
-
Fusion Pharmaceuticals Inc.招聘中宫颈癌 | 乳腺癌 | 卵巢癌 | 子宫内膜癌 | 葡萄膜黑色素瘤 | 肾上腺皮质癌 | 晚期实体瘤 | HER2 阴性乳腺癌 | 三阴性乳腺癌 (TNBC) | 头颈部鳞状细胞癌 (HNSCC)美国, 澳大利亚, 加拿大
-
Fusion Pharmaceuticals Inc.终止乳腺癌 | 胃癌 | 大肠癌 | 卵巢癌 | 肺癌 | 晚期实体瘤 | 头颈部鳞状细胞癌 | 肝癌 | 膀胱癌 | 易感 FGFR3 基因改变 | FGFR3 | FGFR3 过表达 | FGFR3受体 | FGFR3 蛋白过表达美国, 澳大利亚
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University完全的
-
Fusion Pharmaceuticals Inc.AstraZeneca招聘中
-
Weill Medical College of Cornell UniversityMerck Sharp & Dohme LLC; United States Department of Defense招聘中
-
Merck Sharp & Dohme LLC终止
-
Weill Medical College of Cornell UniversityUnited States Department of Defense主动,不招人
-
Bayer招聘中晚期转移性去势抵抗性前列腺癌 | 前列腺特异性膜抗原 (PSMA) 表达加拿大, 英国, 比利时
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
Weill Medical College of Cornell University完全的
-
City of Hope Medical CenterNational Cancer Institute (NCI)招聘中
-
Novartis Pharmaceuticals招聘中转移性去势抵抗性前列腺癌 (mCRPC)法国
-
City of Hope Medical CenterNational Cancer Institute (NCI)招聘中
-
Neuren Pharmaceuticals Limited招聘中
-
Neuren Pharmaceuticals Limited主动,不招人
-
BTS InternationalClinimark, LLC; Guangdong Transtek Medical Electronics Co., Ltd.完全的
-
Weill Medical College of Cornell UniversityConvergent Therapeutics, Inc.撤销
-
Neuren Pharmaceuticals Limited招聘中
-
Institut PasteurCoalition for Epidemic Preparedness Innovations; Themis Bioscience GmbH完全的
-
University of California, Los AngelesNational Institute of Allergy and Infectious Diseases (NIAID); CONRAD完全的
-
Merck Sharp & Dohme LLC尚未招聘艾滋病病毒 | 人类免疫缺陷病毒
-
Merck Sharp & Dohme LLC完全的HIV-1 感染美国, 以色列, 南非